Bells Palsy Physio PDF
Bells Palsy Physio PDF
Bells Palsy Physio PDF
(Review)
This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library
2012, Issue 2
http://www.thecochranelibrary.com
HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Figure 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
DATA AND ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
Analysis 1.1. Comparison 1 Electrostimulation versus control, Outcome 1 Incomplete recovery after 6 and 12 months. 48
Analysis 1.2. Comparison 1 Electrostimulation versus control, Outcome 2 Mean Facial Grading Scale after 3 months. 49
Analysis 1.3. Comparison 1 Electrostimulation versus control, Outcome 3 Incomplete recovery after 3 months. . . 49
Analysis 1.4. Comparison 1 Electrostimulation versus control, Outcome 4 Mean House-Brackmann Facial Grading
Systems. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
Analysis 1.5. Comparison 1 Electrostimulation versus control, Outcome 5 Motor synkinesia after treatment. . . . 50
Analysis 2.1. Comparison 2 Electrostimulation versus prednisone, Outcome 1 Incomplete recovery after six months (all
participants). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
Analysis 2.2. Comparison 2 Electrostimulation versus prednisone, Outcome 2 Incomplete recovery six months according
severity. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
Analysis 2.3. Comparison 2 Electrostimulation versus prednisone, Outcome 3 Mean time to complete recovery (in days). 52
Analysis 3.1. Comparison 3 Exercise versus waiting list, Outcome 1 Recovery on Facial Grading Scale (Sunnybrook scale). 52
Analysis 3.2. Comparison 3 Exercise versus waiting list, Outcome 2 Recovery on Facial Disability Index-physical. . 53
Analysis 3.3. Comparison 3 Exercise versus waiting list, Outcome 3 Recovery on House Brackmann grading system. 53
Analysis 4.1. Comparison 4 Exercise versus conventional treatment, Outcome 1 Incomplete recovery three months after
randomisation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
Analysis 4.2. Comparison 4 Exercise versus conventional treatment, Outcome 2 Mean time from the beginning of the
recovery (in weeks). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
Analysis 4.3. Comparison 4 Exercise versus conventional treatment, Outcome 3 Mean time from completion of recovery
(in weeks). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
Analysis 4.4. Comparison 4 Exercise versus conventional treatment, Outcome 4 Motor synkinesia after treatment. . 56
Analysis 5.1. Comparison 5 Exercise plus acupuncture versus acupuncture, Outcome 1 Number of participants without
recovery. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
Analysis 5.2. Comparison 5 Exercise plus acupuncture versus acupuncture, Outcome 2 Portmann Score. . . . . . 57
Analysis 5.3. Comparison 5 Exercise plus acupuncture versus acupuncture, Outcome 3 Mean House Brackmann score. 58
Analysis 6.1. Comparison 6 Electrotherapy plus acupuncture versus acupuncture, Outcome 1 Number of participants
without recovery. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
Analysis 7.1. Comparison 7 Physical therapy versus acupuncture, Outcome 1 Number of participants without recovery. 59
ADDITIONAL TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
WHAT’S NEW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
HISTORY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
DIFFERENCES BETWEEN PROTOCOL AND REVIEW . . . . . . . . . . . . . . . . . . . . . 68
Physical therapy for Bell’s palsy (idiopathic facial paralysis) (Review) i
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
INDEX TERMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
1
Department of Neurology, Universidade Federal de São Paulo, Camboriu, Brazil. 2 Neuro-Sono, Department of Neurology, Univer-
sidade Federal de São Paulo, São Paulo, Brazil. 3 Department of Neurology, Federal University of São Paulo, São Paulo - SP, Brazil
Contact address: Lázaro J Teixeira, Department of Neurology, Universidade Federal de São Paulo, R. Ana Garcia Pereira, n 167,
Camboriu, Santa Catarina, 88340-970, Brazil. [email protected].
Citation: Teixeira LJ, Valbuza JS, Prado GF. Physical therapy for Bell’s palsy (idiopathic facial paralysis). Cochrane Database of Systematic
Reviews 2011, Issue 12. Art. No.: CD006283. DOI: 10.1002/14651858.CD006283.pub3.
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
ABSTRACT
Background
Bell’s palsy (idiopathic facial paralysis) is commonly treated by various physical therapy strategies and devices, but there are many
questions about their efficacy.
Objectives
Search methods
We searched the Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled Trials (The Cochrane
Library, Issue 1, 2011), MEDLINE (January 1966 to February 2011), EMBASE (January 1946 to February 2011), LILACS (January
1982 to February 2011), PEDro (from 1929 to February 2011), and CINAHL (January 1982 to February 2011). We included searches
in clinical trials register databases until February 2011.
Selection criteria
We selected randomised or quasi-randomised controlled trials involving any physical therapy. We included participants of any age with
a diagnosis of Bell’s palsy and all degrees of severity. The outcome measures were: incomplete recovery six months after randomisation,
motor synkinesis, crocodile tears or facial spasm six months after onset, incomplete recovery after one year and adverse effects attributable
to the intervention.
Two authors independently scrutinised titles and abstracts identified from the search results. Two authors independently carried out
risk of bias assessments, which took into account secure methods of randomisation, allocation concealment, observer blinding, patient
blinding, incomplete outcome data, selective outcome reporting and other bias. Two authors independently extracted data using a
specially constructed data extraction form. We undertook separate subgroup analyses of participants with more and less severe disability.
Physical therapy for Bell’s palsy (idiopathic facial paralysis) (Review) 1
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Main results
For this update to the original review, the search identified 65 potentially relevant articles. Twelve studies met the inclusion criteria (872
participants). Four trials studied the efficacy of electrical stimulation (313 participants), three trials studied exercises (199 participants),
and five studies compared or combined some form of physical therapy with acupuncture (360 participants). For most outcomes we
were unable to perform meta-analysis because the interventions and outcomes were not comparable.
For the primary outcome of incomplete recovery after six months, electrostimulation produced no benefit over placebo (moderate
quality evidence from one study with 86 participants). Low quality comparisons of electrostimulation with prednisolone (an active
treatment) (149 participants), or the addition of electrostimulation to hot packs, massage and facial exercises (22 participants), reported
no significant differences. Similarly a meta-analysis from two studies, one of three months and the other of six months duration (142
participants) found no statistically significant difference in synkinesis, a complication of Bell’s palsy, between participants receiving
electrostimulation and controls. A single low quality study (56 participants), which reported at three months, found worse functional
recovery with electrostimulation (mean difference (MD) 12.00 points (scale of 0 to 100) 95% confidence interval (CI) 1.26 to 22.74).
Two trials of facial exercises, both at high risk of bias, found no difference in incomplete recovery at six months when exercises were
compared to waiting list controls or conventional therapy. There is evidence from a single small study (34 participants) of moderate
quality that exercises are beneficial on measures of facial disability to people with chronic facial palsy when compared with controls
(MD 20.40 points (scale of 0 to 100), 95% CI 8.76 to 32.04) and from another single low quality study with 145 people with acute
cases treated for three months, in which significantly fewer participants developed facial motor synkinesis after exercise (risk ratio 0.24,
95% CI 0.08 to 0.69). The same study showed statistically significant reduction in time for complete recovery, mainly in more severe
cases (47 participants, MD -2.10 weeks, 95% CI -3.15 to -1.05) but this was not a prespecified outcome in this meta analysis.
Acupuncture studies did not provide useful data as all were short and at high risk of bias. None of the studies included adverse events
as an outcome.
Authors’ conclusions
There is no high quality evidence to support significant benefit or harm from any physical therapy for idiopathic facial paralysis. There
is low quality evidence that tailored facial exercises can help to improve facial function, mainly for people with moderate paralysis and
chronic cases. There is low quality evidence that facial exercise reduces sequelae in acute cases. The suggested effects of tailored facial
exercises need to be confirmed with good quality randomised controlled trials.
Secondary outcomes
Criteria for considering studies for this review
1. The presence of motor synkinesis, contracture,
hyperkinesia, facial spasm or crocodile tears preferably six
months after onset.
Types of studies
2. Incomplete recovery after one year.
We included all randomised or quasi-randomised (alternate or 3. Adverse effects attributable to the intervention such as pain
other systematic allocation) controlled trials involving any physical or worsening of condition.
therapy compared with no treatment, placebo treatment, drug In a future update we will consider a change in the protocol to
treatment, acupuncture or other physical therapy interventions. include ’time to recovery’ as a secondary outcome measure.
Types of participants
We included participants with a diagnosis of Bell’s palsy, defined Search methods for identification of studies
as idiopathic lower motor neuron facial palsy of sudden onset. We searched the Cochrane Library - Cochrane Database of Sys-
We included participants of any age, and all degrees of severity. tematic Reviews (Cochrane Reviews) and the Cochrane Cen-
We did not include people with facial palsy due to Ramsay-Hunt tral Register of Controlled Trials (The Cochrane Library, Issue 1,
syndrome or other recognised causes. 2011), and PEDro (from 1929 to February 2011) using the terms
’Bell’s palsy’ or ’idiopathic facial paralysis’ or ’facial palsy’. We
also searched MEDLINE (January 1966 to February 2011), EM-
Types of interventions
BASE (January 1947 to February 2011), LILACS (January 1982
We included trials of any form of physical therapy treatment com- to February 2011) and CINAHL (January 1982 to February 2011)
pared with either no treatment, drugs or an alternative form of according to a specific search strategy (see Appendices). We also
non-drug treatment. We considered physical therapy to be the searched clinical trial databases in February 2011(see searching
use of any physical agents, such as heat, light, cold, sound, water, other resources above).
electricity, manual therapy and other gadgets working on phys-
ical principles in treatment. Types of physical therapy interven-
tions for facial palsy included facial exercises, such as strengthening Electronic searches
and stretching; endurance; therapeutic and facial mimic exercises We constructed specific search strategies for the different
(“mime therapy”) (Beurskens 2003); electrotherapy; biofeedback; databases. For a complete description, see Appendix 1 (MED-
transcutaneous electrical nerve stimulation (TENS) or electrical LINE), Appendix 2 (EMBASE), Appendix 3 (CINAHL),
neural muscular stimulation (ENMS); thermal methods; and mas- Appendix 4 (LILACS), Appendix 5 (PEDro).
sage, alone or in combination with any other therapy.
Searching other resources
Types of outcome measures 1. We checked references of all identified trials.
2. We contacted physical therapy companies in order to
obtain data on unpublished trials.
Primary outcomes 3. We contacted first authors of all included trials for further
The primary outcome measure was incomplete recovery preferably information or information regarding unpublished trials.
six months after randomisation. We defined incomplete recovery 4. We consulted databases of ongoing trials. We searched the
in two ways. We considered participants who had House-Brack- World Health Organization (WHO) International Clinical Trials
mann Facial Grading System (House 1985) grade III (moderate Registry Platform (http://apps.who.int/trialsearch), Current
dysfunction) or worse at entry to have incomplete recovery if they Controlled Trials (http://www.controlled-trials.com), the
still had House-Brackmann Grade III or worse after treatment. National Institute for Health Research Register (NRR) Archive (
For participants who had House-Brackmann grade II at entry, http://www.nihr.ac.uk/Pages/NRRArchiveSearch.aspx), the US
REFERENCES
References to studies included in this review Wen 2004 {unpublished data only}
Wen CM, Zhang BC. Effect of rehabilitation training at
Alakram 2010 {published and unpublished data}
different degree in the treatment of idiopathic facial palsy: a
Alakram P, Puckree T. Effects of electrical stimulation on
randomized controlled comparison. Zhongguo Linchuang
House-Brackmann scores in early Bell’s palsy. Physiotherapy
Kangfu 2004;8(13):2446–7.
Theory and Practice 2010;26(3):160–6.
Wong 2004 {unpublished data only}
Barbara 2010 {published data only}
Wong XH, Zhang LM, Han M, Zhang KQ. Clinical
Barbara M, Antonini G, Vestri A, Volpini L, Monini S. Role
application of functional exercise and staged therapy in
of Kabat physical rehabilitation in Bell’s palsy: a randomized
treatment of facial nerve paralysis. Zhonghua Linchuang
trial. Acta Oto-Laryngologica 2010;130(1):167–72. [DOI:
Kangfu Zazhi [Chinese Journal of Experimental and Clinical
10.1080/00016480902882469]
Virology] 2004;8(4):616–7.
Beurskens 2003 {published and unpublished data}
Yang 2001 {published data only}
Beurskens C. Mime therapy: rehabilitation of facial
Yang G. Comparison of the efficacy between acupuncture
expression. Nederlands Tijdschrift Voor Fysiotherapie 2007;
and therapy apparatus for Bell’s palsy. Journal of Clinical
117(3):76–7.
Acupuncture & Moxibustion 2001;17(8):28–9.
Beurskens CHG, Heymans PG. Mime therapy improves
facial symmetry in people with long-term facial nerve Zhang 2005 {published data only}
paresis: a randomized controlled trial. Australian Journal of Zhang H. Acupuncture combined with facial muscle
Physiotherapy 2006;52(3):177–83. training for peripheral facial paralysis. Chinese Journal of
∗
Beurskens CHG, Heymans PG. Positive effects of mime Rehabilitation Theory and Practice 2005;11(12):1037–8.
therapy on sequelae of facial paralysis: stiffness, lip mobility,
References to studies excluded from this review
and social and physical aspects of facial disability. Otology &
Neurotology 2003;24(4):677–81. Adour 1971 {published data only}
Beurskens CHG, Heymans PG, Oostendorp RAB. Stability Adour KK, Swanson, PJ Jr. Facial paralysis in 403
of benefits of mime therapy in sequelae of facial nerve consecutive patients: emphasis on treatment response in
paresis during a 1-year period. Otology & Neurotology 2006; patients with Bell’s palsy. Transactions American Academy
27(7):1037–42. of Ophthalmology and Otorinolaryngology 1971;75(6):
Flores 1998 {published data only} 1284–301.
Flores PF, Medina RZ, Haro LG. Idiopathic peripheral Aleev 1973 {unpublished data only}
facial paralysis treatment physic therapy versus prednisone Aleev LS. Experience in the treatment of facial nerve
[Tratamiento de la parálisis facial periférica idiopática: neuritis using the method of programmed multi-channel
terapia física versus prednisona]. Revista médica del Instituto bioelectrical control. Zhurnal Nevropatologii i Psikhiatrii
Mexicano del Seguro Social 1998;36(3):217–21. Imeni S. S. Korsakova 1973;73(3):345–50.
Manikandan 2007 {published and unpublished data} Balliet 1982 {published data only}
Manikandan N. Effect of facial neuromuscular re- Balliet R, Shinn JB, Bach-y-Rita P. Facial paralysis
education on facial symmetry in patients with Bell’s palsy: a rehabilitation: retraining selective muscle control.
randomized controlled trial. Clinical Rehabilitation 2007; International Rehabilitation Medicine 1982;4(2):67–74.
21(4):338–43. Bernardes 2004 {published data only}
Mosforth 1958 {published data only} Bernardes DF, Gomez MV, Pirana S, Bento RF. Functional
Mosforth J, Taverner D. Physiotherapy for Bell’s palsy. profile in patients with facial paralysis treated in a
British Medical Journal 1958;2(5097):675–7. myofunctional approach. Pró-fono 2004;16(2):151–8.
Pan 2004 {published data only} Beurskens 2004c {published data only}
Pan L. Acupuncture plus short wave for 38 peripheral facial Beurskens CHG, Devriese PP, van Heiningen I, Oostendorp
paralysis. Journal of Clinical Acupuncture & Moxibustion RAB. The use of mime therapy as a rehabilitation method
2004;20(4):26–7. for patients with facial nerve paresis. International Journal of
Qu 2005 {unpublished data only} Therapy and Rehabilitation 2004;11(5):206–10.
Qu Y. Clinical observation on acupuncture by stages Brach 1999 {published data only}
combined with exercise therapy for treatment of Bell palsy Brach JS, VanSwearingen JM. Physical therapy for facial
at acute stage. Zhongguo Zhen Jiu [Chinese Acupuncture & paralysis: a tailored treatment approach. Physical Therapy
Moxibustion] 2005;25(8):545–7. 1999;79(4):397–404.
Physical therapy for Bell’s palsy (idiopathic facial paralysis) (Review) 18
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Brown 1978 {published data only} biofeedback technique - Muscle relaxation technique. Acta
Brown DM, Nahai F, Wolf S, Basmajian JV. Clinica Croatica 1996;35(1-2):17–20.
Electromyographic biofeedback in the reeducation of facial Fombeur 1988 {published data only}
palsy. American Journal of Physical Medicine 1978;57(4): Fombeur J, Koubbi G, Chevalier AM, Mousset C. On
183–90. the contribution of magnets in sequelae of facial paralysis.
Cai 2010 {published data only} Preliminary clinical study. Annales d Oto-Laryngologie et de
Cai ZG, Shi XJ, Lu XG, Yang ZH, Yu GY. Efficacy of Chirurgie Cervico-Faciale 1988;105(5):397–402.
functional training of the facial muscles for treatment of
Gómez-Benítez 1995 {published data only}
incomplete peripheral facial nerve injury. The Chinese
Gómez-Benítez DA, Rivas JAC, García EF, Peña DSM,
Journal of Dental Research 2010;13(1):37–43.
Méndez Torres L, Pantaleon Z. Physical therapy in a
Casler 1990 {published data only} population of patients with peripheral facial paralysis.
Casler JD, Conley J. Simultaneous ’dual system’ Revista Medica Dominicana 1995;56(1):22–4.
rehabilitation in the treatment of facial paralysis. Archives
Goulart 2002 {published data only}
of Otolaryngology Head and Neck Surgery 1990;116(12):
Goulart F, Vasconcelos KSS, Souza MRV, Pontes PB.
1399–403.
Physical therapy for facial paralysis using the biofeedback [A
Coulson 2006a {published data only} utilização do biofeedback no tratamento da paralisia facial
Coulson SE, Adams RD, O’Dwyer NJ, Croxson GR. periférica]. Acta Fisiátrica 2002;9(3):134–40.
Physiotherapy rehabilitation of the smile after long-
Guo 2006 {published data only}
term facial nerve palsy using video self-modeling and
implementation intentions. Otolaryngology - Head and Neck Guo QH, Yan JZ, Yan WS, Xiao MZ. Observation on non-
invasive electrode pulse electric stimulation for treatment of
Surgery 2006;134(1):48–55.
Bell’s palsy. Zhongguo Zhenjiu 2006;26(12):857–8.
Coulson 2006b {published data only}
Coulson SE, Adams RD, O’Dwyer NJ, Croxson GR. Use Hou 2008 {published data only}
of video self-modelling and implementation intentions Hou Y, Li Z, Ouyang Q, Li X, Li H, Zhao M. Observation
following facial nerve paralysis. International Journal of on therapeutic effect of acupuncture combined with He-Ne
Therapy and Rehabilitation 2006;13(1):30–5. laser radiation on facial paralysis. Zhongguo Zhen Jiu 2008;
28(4):265–6.
Cronin 2003 {published data only}
Klingler 1982 {published data only}
Cronin GW, Steenerson RL. The effectiveness of
Klingler D, Bibl D. Peripheral facial paralysis-role of early
neuromuscular facial retraining combined with
onset of therapy. Wiener Medizinische Wochenschrift 1982;
electromyography in facial paralysis rehabilitation.
132:149–53.
Otolaryngology - Head and Neck Surgery 2003;128(4):534–8.
Koyama 2005 {unpublished data only}
Cui 2009 {published data only}
Koyama S, Okada K, Yamakawa T, Kubo M, Amatsu H.
Cui CB, Yang JS, Rong PJ, Zhu B, Liu JY, Han Y, et
The usefulness of manipulative physiotherapy in treating
al.Observation on therapeutic effect of Hwato never and
Bell’s palsy. Medical Journal of Minami Osaka Hospital 2005;
muscle stimulator on peripheral facial paralysis. Chinese
53(1):55–7.
Acupuncture & Moxibustion 2009;29(5):421–3.
Krukowska 2004 {published data only}
Dalla-Toffola 2005 {published and unpublished data} Krukowska J, Czernicki J, Zalewski P. Influence of steroid
Dalla-Toffola E, Bossi D, Buonocore M, Montomoli C, therapy local injection of steroidal in the region of the
Petrucci L, Alfonsi E. Usefulness of BFB/EMG in facial stylomastoid foramen and physiotherapy on the recovery
palsy rehabilitation. Disability and Rehabilitation 2005;27 of stapedial reflex in patients with facial nerve paralysis.
(14):809–15. Otolaryngologia Polska 2004;58(6):1081–9.
Danile 1982 {published data only}
Li 2005 {published data only}
Danile V, Marongiu A, Candioto G. New therapeutic
Li J. Comparison the efficacy between acupuncture and
method by ionophoresis of a drug cocktail in facial paralysis
manipulation for Bell’s palsy. Chinese Clinical Medicine
a frigore [Nuovo metodo terapeutico ionoforetico con
Research 2005;11(12):1715–6.
cocktail medicamentoso della paresi facciale a frigore].
Policlinico - Sezione Medica 1982;89(2):160–6. Lobzin 1989 {unpublished data only}
∗
Lobzin VS, Smetankin AA, Tsatskina ND, Iashin NS.
Diao 2002 {published data only}
Treatment of Bell’s palsy by using portable biofeedback
Diao LH, Zhang FE, Wang C. Applying acupuncture and
devices. Zhurnal Nevropatologii i Psikhiatrii Imeni S. S.
moxibustion to treating peripheral facial paralysis. Journal
Korsakova 1989;89(10):57–62.
of Huaihua Medical College 2002;1(2):34–5.
Lobzin VS, Tsatskina ND. The adaptive biological control
Dubravica 1996 {published data only} system with electromyographic feedback in the treatment of
Dubravica M, Musura M, Nesek-Madaric V, Stajner- Bell’s palsy [Russian]. Zhurnal Nevropatologii i Psikhiatrii
Katusic S, Horga D. Treatment of facial palsy by EMG Imeni S. S. Korsakova 1989;89(5):54–7.
Physical therapy for Bell’s palsy (idiopathic facial paralysis) (Review) 19
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Lu 2006 {unpublished data only} Taverner 1966 {published data only}
Lu Z-x. Clinical observation on acupuncture plus laser Taverner D, Fearnley ME, Kemble F, Miles DW, Peiris OA.
radiation for treatment of facial spasm. Zhongguo Zhenjiu Prevention of denervation in Bell’s palsy. British Medical
2006;26(7):475–6. Journal 1966;5484:391–3.
Manca 1997 {published data only} Tessitore 2009 {published data only}
Manca M, Contenti E, Mura G, Basaglia N, Cavazzini Tessitore A, Paschoal JR, Pfeilsticker LN. Peripheral facial
L. EMG biofeedback in peripheral facial nerve palsy paralysis: evaluation of an orofacial rehabilitation protocol.
rehabilitation. Europa Medicophysica 1997;33(3):143–7. Revista CEFAC 2009;11(Sup 3):432–40.
Yang 2009a {published data only}
Murakami 1993 {published data only}
Yang Y, Zhang W, Zhu JP. Clinical observation on
Murakami F, Kemmotsu O, Kawano Y, Matsumura C,
therapeutic effect of different acupuncture therapies on
Kaseno S, Imai M. Diode low reactive level laser therapy
acute peripheral facial paralysis. Chinese acupuncture &
and stellate ganglion block compared in the treatment of
moxibustion 2009;29(6):452–4.
facial palsy. Laser Therapy 1993;5(3):131–5.
Yang 2009b {published data only}
Nakamura 2003 {published data only} Yang JS, Cui CB, Gao XY, Zhu B, Rong PJ. 44 cases of
Nakamura K, Toda N, Sakamaki K, Kashima K, Takeda N. peripheral facial paralysis treated by the SXDZ-100 nerve
Biofeedback rehabilitation for prevention of synkinesis after and muscle stimulator. Journal of Traditional Chinese
facial palsy. Otolaryngology - Head and Neck Surgery 2003; medicine 2009;29(3):182–5.
128(4):539–43.
Zhao 2005 {published data only}
Ortega-Torres 2009 {published data only} Zhao Y, He L, Zhang QH. Effectiveness of three different
Ortega-Torres SE. Treatment of acute peripheral facial treatments for peripheral facial paralysis. Chinese Journal of
paralysis with microdoses of laser. Neurologia, Neurocirugia Clinical Rehabilitation 2005;9(29):41–3.
y Psiquiatria 2009;42(1):1–4.
References to studies awaiting assessment
Penteado 2009 {published and unpublished data}
Penteado TC, Testa JRG, Antunes ML, Chevalier AM. Chen 1995 {published data only}
Evaluation of the Chevalier method for the prevention of Chen XJ, Yang DH. Treatment of facial paralysis using low
sequelae after peripheral facial nerve palsy [Évaluation de frequency current therapy and light therapy. Chinese Journal
la technique Chevalier pour la prévention des séquelles of Physical Therapy 1995;18(3):185–6.
dans la paralysie faciale périphérique – French]. La
Shen 1998 {published data only}
Revue Kinésithérapie 2009;9(90):40–7. [DOI: 10.1016/
Shen ZL. Physicotherapy for 148 cases with peripheral facial
S1779-0123(09)74656-X]
paralysis. Chinese Journal of Physical Therapy 1998;21(3):
Romero 1982 {published data only} 186–7.
Corral-Romero MA, Bustamante-Balcarcel A. Biofeedback Tang 2002 {published data only}
rehabilitation in seventh nerve paralysis. The Annals of Tang HY, Tan H, Zhang X. The improving-muscal-
Otology, Rhinology, and Laryngology 1982;92(2 Pt 1):166–8. trainning on idiopathic facial palsy. Chinese Journal of
Clinical Rehabilitation 2002;6(5):643–58.
Ross 1991 {published data only}
Ross B, Nedzelski J, Mclean J. Efficacy of feedback training Wang 1995a {published data only}
in long-standing facial paresis. Laryngoscope 1991;101(7 Pt Wang H, Ye CS. Observation of ultra-short wave,
1):744–50. interference current on 73 cases with idiopathic facial
paralysis. Chinese Journal of Physical Therapy 1995;18(3):
Segal 1995a {published data only} 172–3.
Segal B, Hunter T, Danys I, Freedman C, Black M.
Wang 1995b {published data only}
Minimizing synkinesis during rehabilitation of the paralyzed
Wang XL, Jin SZ, Liu DX, Xie QR, Xiao HY. Medium
face: Preliminary assessment of a new small-movement
frequency current therapy for Bell’s paralysis. Chinese
therapy. Journal of Otolaryngology 1995;24(3):149–53.
Journal of Physical Therapy 1995;18(1):55–7.
Segal 1995b {published data only} Wang 1999 {published data only}
Segal B, Zompa L, Danys I, Black M, Shapiro M, Melmed Wang QZ. Observation of the therapeutic effects of
C, et al.Symmetry and synkinesis during rehabilitation of acupuncture and laser treatment on facial spasm. Chinese
unilateral facial paralysis. Journal of Otolaryngology 1995;24 Acupuncture 1999;19(12):715–6.
(3):143–8.
Wang 2004 {published data only}
Shiau 1995 {published data only} Wang XH, Zhang LM, Han M, Zhang KQ, Jiang JJ.
Shiau J, Segal B, Danys I, Freedman R, Scott S. Long-term Treatment of Bell’s palsy with combination of traditional
effects of neuromuscular rehabilitation of chronic facial Chinese medicine and western medicine. West China
paralysis. The Journal of Otolaryngology 1995;24(4):217–20. Journal of Stomatology Stomatology 2004;22(3):211–3.
Physical therapy for Bell’s palsy (idiopathic facial paralysis) (Review) 20
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Yao 1994 {published data only} Gilden 2004
Yao RM. Physical therapy for facial paralysis. Chinese Gilden DH. Clinical Practice. Bell’s palsy. The New England
Journal of Physical Therapy 1994;17(3):169. Journal of Medicine 2004;351(13):1323–31.
Zhang 2003 {published data only} Gonçalvez 1997
Zhang L. Observations on the effect of Laser plus Gonçalvez-Coêlho TD, Pinheiro CN, Ferraz EV, Alonso-
acupuncture in treatment of peripheral facial paralysis. Nieto JL. Clusters of Bell’s palsy. Arquivos de Neuro-
Shanghai Journal of Acupuncture and Moxibustion 2003;22 Psiquiatria 1997;55(4):722–7.
(12):11–2. GRADE 2004
Zhuo 1990 {published data only} GRADE working group. Grading quality of evidence and
Zhuo QSAU, Hou XAU, Li YH. Treatment of 109 cases of strength of recommendations. British Medical Journal 2004;
facial paralysis. Chinese Journal of Physical Therapy 1990;13 328:1490–4.
(3):179. GRADEPro 2008
GRADEpro. 3.2 for Windows. Jan Brozek, Andrew
Additional references Oxman, Holger Schünemann 2008.
Alakram 2010
Methods Analysis: differences between the experimental and control group and between pre- and
post-tests
Treatment duration: 3 months after onset of Bell’s palsy or until the patient recovered a
minimum of 80% on the House-Brackmann Facial Nerve Grading System
Follow-up: no
Center: University of KwaZulu Natal, South Africa
Design: randomised clinical trial
Notes Both groups were treated once a week due to the inability of patients to attend the
outpatient clinic more frequently
Risk of bias
Allocation concealment (selection bias) High risk Alllocation by alternation so there was no
allocation concealment
Incomplete outcome data (attrition bias) High risk There were 6 drop outs: 3 people in each
All outcomes group of 11, corresponding to 27%. No
reasons were given but the number was
equivalent in the control and experimental
group. There were no major adverse events
Selective reporting (reporting bias) Low risk The published reports include all expected
outcomes
Other bias High risk The study length was very short (12 weeks)
. There was no follow-up
Barbara 2010
Participants N = 20 participants.
Diagnosis: people affected by idiopathic facial palsy with House-Brackmann ≥ 3/6,
within 3 days after onset. The viral origin was supported by positive serology for antibod-
ies against herpes virus 1, negative otoneurological examination, and normal gadolin-
ium-enhanced MRI
Duration of the palsy: no more than 3 days (acute cases)
Gender: both sexes (10 males and 10 females)
Race: not mentioned
Age: therapy group mean 35 (25 to 58) years old, and control group 42 (28 to 56) years
old
Setting: unclear
Notes
Risk of bias
Incomplete outcome data (attrition bias) Low risk All patients completed the study and there
All outcomes were no losses to follow-up, no treatment
withdrawals, no trial group changes and no
major adverse events but there was no fol-
low-up
Selective reporting (reporting bias) Low risk The published reports include all expected
outcomes
Other bias High risk The study duration was very short (15 days)
Blinding of participants and personnel High risk Participant blinding not done
(performance bias)
All outcomes
Blinding of outcome assessment (detection Unclear risk Assessor blinding not clear
bias)
All outcomes
Methods Analysis: differences (between the experimental and control group and between pre-
and post-tests). Data were collected concerning the level of impairment, disability, and
handicap of the patient in pre-test and post-test measures in both the treatment and the
control groups
Duration: 3 months of therapy
Follow-up: 3 measurement occasions within 1 year: immediately, 3 and 12 months after
therapy
Center: Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
and Vrije Universiteit Medical Center, Amsterdam
Design: randomised clinical trial
Participants N = 50 peripheral facial nerve paresis (34 idiopathic facial palsy considered in the analysis)
Diagnosis: people with sequelae of facial paralysis, House-Brackmann IV, for at least 9
months; no nerve or muscle reconstruction; absence of complete, partial, or central facial
paralysis; absence of congenital facial paralysis; and sufficient knowledge of the Dutch
language
Duration of the palsy: more than 9 months (chronic cases)
Gender: both sexes (21 males and 29 females), including the participants with other
causes of facial palsy
Race: not mentioned
Age: median 44 years (20 to 73, SD 14) including the participants with other causes of
facial palsy
Setting: physiotherapy outpatient department
Outcomes Stiffness of the face. Lip mobility (both lip and pout length)
Physical and social index of the Facial Disability Index (VanSwearingen 1996)
Sunnybrook Facial Grading System.
House-Brackmann Facial Grading System
Notes This study description is the pool of three publications by the author about the same
population and groups
Risk of bias
Allocation concealment (selection bias) High risk A coin flip for the first participant and then
pairs of patients as they became available
Incomplete outcome data (attrition bias) Low risk All participants completed the study and
All outcomes there were no losses to follow-up, no treat-
ment withdrawals, no trial group changes
Selective reporting (reporting bias) Low risk The published reports include all expected
outcomes
Blinding of participants and personnel High risk Participant blinding not done
(performance bias)
All outcomes
Blinding of outcome assessment (detection Low risk The outcome assessors were unaware of the
bias) allocation
All outcomes
Flores 1998
Methods Analysis: the participants were divided, for purposes of analysis, into those with and
those without electromyographic evidence of denervation
Duration: until functional recovery was achieved according to the May Scale, with eval-
uations every 14 days
Follow-up: not described.
Center: Medicina Física y Rehabilitacion Department, Hospital General Regional Num
1, Culiacán, Sinaloa, México
Design: randomised clinical trial
Participants N = 149
Diagnosis: EMG 8 days after onset. Excluded other causes of facial paralysis
Duration of the palsy: acute cases acute of onset within 1 to 3 days
Gender: both sexes (males 61 and females 88)
Race: not mentioned
Age: median 33 (3 to 60) years
Setting: clinic
History/comorbidities: normal glycaemia and arterial pressure
Outcomes Clinical history and May Scale (grade I - complete recovery, II - complete recovery with
facial asymmetry with movements between 2 to 6 months, and III - incomplete recovery
with asymmetry, synkinesis for more than 6 months)
Notes
Risk of bias
Incomplete outcome data (attrition bias) High risk Drop out: 29 people (19.26%) dropped
All outcomes out and the study does not describe the ex-
act reason for drop out or the groups they
were allocated to. Reasons: participants re-
quested another medication or they did not
adhere to the treatment
Selective reporting (reporting bias) Low risk The published reports include all expected
outcomes
Blinding of participants and personnel High risk Participant blinding not done
(performance bias)
All outcomes
Blinding of outcome assessment (detection High risk Assessor blinding not done
bias)
All outcomes
Manikandan 2007
Methods Analysis: the authors used Wilcoxon signed-rank test and Mann Whitney U-test to
compare the Facial Grading Scale scores within each group
Duration: 3 months of therapy
Follow-up: 3 months. Until the end of the therapy
Center: Kasturba Hospital, Manipal, Karnataka, India
Design: randomised clinical trial
Participants N = 59 participants.
Diagnosis: unilateral Bell’s palsy
Excluded people with diseases of the central nervous system, sensory loss over the face,
recurrence of facial paralysis and who were uncooperative during the study
Duration of the palsy: a mean duration of 2 weeks
Gender: both sexes (males 24 and females 37)
Race: not mentioned
Age: median of 35 years old
Setting: neurorehabilitation unit
History/comorbidities: not described
Outcomes Facial Grading Scale (facial symmetry at: rest, movement and synkinesis) before and after
3 months
Notes
Risk of bias
Allocation concealment (selection bias) Low risk Randomisation using 6 blocks with 10 in
each block
Incomplete outcome data (attrition bias) Low risk Adverse events: 2 participants in group 2
All outcomes developed mild synkinesis post treatment
Drop outs: one participant from group 1
and two from group 2 dropped out before
the completion of the study with reasons
stated
Selective reporting (reporting bias) Low risk The published reports include all expected
outcomes
Other bias High risk The study time was very short (90 days).
There was no follow-up
Blinding of participants and personnel High risk Participant blinding not done
(performance bias)
All outcomes
Blinding of outcome assessment (detection High risk Assessor blinding not done
bias)
All outcomes
Methods Analysis: The participants were divided, for purposes of analysis, into those with and
those without electromyographic evidence of denervation
Duration: the treatment was given daily until the active contractions returned and then
thrice weekly until recovery was virtually complete or the condition seemed stationary
(2 to 6 months)
Follow-up: 1 year
Center: Department of Electromyography Leeds General Infirmary
Design: controlled randomised trial
Interventions 1. Auto-massage of the face plus infrared for 10 min plus interrupted galvanic
stimulation of 11 muscles of the face 3 times for 30 contractions (pulse 100 msec). N =
44
2. Massage. N = 42
Notes
Risk of bias
Incomplete outcome data (attrition bias) Low risk One patient from group 1 and two from
All outcomes group 2 dropped out before the completion
of the study with reasons
Selective reporting (reporting bias) Low risk The published reports include all expected
outcomes
Blinding of participants and personnel High risk Participant blinding not done
(performance bias)
All outcomes
Blinding of outcome assessment (detection High risk Assessor blinding not done
bias)
All outcomes
Pan 2004
Methods Analysis: the participants were analysed according to the grade of recovery after one
month of therapy to evaluate the results
Duration: the treatment once every other day for 30 days lasting for 1 month
Follow-up: not done
Center: not described
Design: randomised clinical trial
Outcomes The treatment results were classified as: full recovery, effective, no effect
Full recovery: eyes closed properly, symmetric wrinkles appears on the forehead and
beside nose; able to blow up the cheeks and show teeth
Effective: almost has symmetric wrinkles on the forehead and beside nose; almost able
to blow up the cheeks and show teeth
No effect: asymmetric wrinkles on the forehead and beside nose; unable to close eyes or
blow up the cheeks
Measurements were at day 10, 20 and 30. There was one course of treatment every 10
days
Notes
Risk of bias
Incomplete outcome data (attrition bias) Low risk All patients completed the study and there
All outcomes were no losses to follow-up, no treatment
withdrawals, no trial group changes and no
major adverse events, but there was no fol-
low-up
Selective reporting (reporting bias) Low risk The published reports include all expected
outcomes
Blinding of participants and personnel High risk Participant blinding not described
(performance bias)
All outcomes
Blinding of outcome assessment (detection High risk Assessor blinding not described
bias)
All outcomes
Qu 2005
Methods Analysis: according to House-Brackmann criteria, the treatment outcome was categorised
as: cure, excellent, improved or ineffective
Duration: 58 days. The treatment period was 5 courses; 10 days constituted one course.
Follow-up: until the end of the therapy
Center: Zigui County Second Hospital, Hubei 443600, China
Design: randomised clinical trial
Outcomes House-Brackmann Grading was grouped into four kinds (cure, excellent, improved and
ineffective) after two months
Notes
Risk of bias
Random sequence generation (selection High risk Based on the order of arrival
bias)
Incomplete outcome data (attrition bias) Low risk All patients completed the study and there
All outcomes were no losses to follow-up, no treatment
withdrawals, no trial group changes and no
major adverse events, but there was no fol-
low-up
Selective reporting (reporting bias) Low risk The published reports include all expected
outcomes
Other bias High risk The study time was very short (58 days).
There was no follow-up
Blinding of participants and personnel High risk Participant blinding not described
(performance bias)
All outcomes
Blinding of outcome assessment (detection High risk Assessor blinding not described
bias)
All outcomes
Methods Analysis: each group has patients with three different severities: mild, moderate and
severe. The degree of recovery, time to recovery and complications were used to evaluate
the results
Follow-up: during the treatment, i.e.12 weeks (between 10/2000 and 11/2003)
Center: Central Hospital of Nanyanz, Manyang, Henan Province, China
Design: controlled randomised trial
Interventions 1. Conventional therapy plus facial rehabilitation exercises (movements using facial mus-
cles, exercises performed daily under the tutoring of clinicians). N = 85
2. Conventional therapy only. N = 60
Both groups received the same pharmacological treatment, described as conventional
therapy but neither the medicine nor the dosage was described)
Outcomes Grade of paralysis estimated visually as a percentage of the function of the normal side
The outcome measures were times when the patient started to recover and completely
recovered; the percentage of completely recovered patients within 12 weeks
The measurements took place once a week by clinicians but the results were presented
as standard mean differences. No baseline level was indicated
Notes
Risk of bias
Incomplete outcome data (attrition bias) Low risk Facial muscle synkineses were reported in
All outcomes one participant in the mild and one in the
moderate group. In the group of partici-
pants with severe disease, 12 had compli-
cations in the control group and 4 in the
training group, but drop outs were not de-
scribed. There was no follow-up
Selective reporting (reporting bias) Low risk The published reports include all expected
outcomes
Other bias High risk The study duration was very brief (3
months)
Blinding of participants and personnel High risk Participant blinding not described
(performance bias)
All outcomes
Blinding of outcome assessment (detection High risk Assessor blinding not described
bias)
All outcomes
Wong 2004
Methods Analysis: improvement index = (scores after treatment - scores before treatment)/scores
after treatment
Duration: 1 month (30 days)
Follow-up: 1 month. Until the end of the therapy
Center: Neurology Department of West China Hospital
Design: randomised clinical trial
Interventions 1. Drug plus physical treatment plus massage plus acupuncture plus functional exercise.
N = 43
• 1 to 7 days - drug treatment and physical treatment.
• 8 to 14 days - drug treatment, physical treatment, functional exercise and massage
and acupuncture treatment
• 14 to 30 days - physical treatment, functional exercise and massage and
acupuncture treatment
2. Drug plus physical treatment plus massage plus acupuncture. N = 31
• 1 to 7 days - drug treatment and physical treatment
• 8 to 14 days - physical treatment and massage and acupuncture treatment
• 14 to 30 days - physical treatment and massage and acupuncture treatment
Drug treatment (cortisone 30 mg daily in the morning or 10 mg 3 x daily for 7 days,
decreased dosage on the 7th day, and stopped on the 14th day; mecobalamin 500 ug 2
x daily; vitamin B2 10 mg)
Outcomes Scores of facial muscular function: Portmann Scores (frowning, eyes closing, moving
nose, smiling, whistling, and plumping the face, each movement graded 3 scores, adding
2 scores for the impression of quiet state)
Notes This same research group have two trials (Wong 2004; Wang 2004) published in the
same year with the same study design, similar groups, similar outcomes and similar results
described in the abstract, but we could not source Wang 2004, reason to classified it in
studies awaiting classification category
Risk of bias
Allocation concealment (selection bias) Low risk Randomised numbers by the computer
Incomplete outcome data (attrition bias) Low risk All participants completed the study and
All outcomes there were no losses to follow-up, no treat-
ment withdrawals, no trial group changes
and no major adverse events, but there was
no follow-up
Selective reporting (reporting bias) Low risk The published reports include all expected
outcomes
Other bias High risk There was no exact criterion to measure the
symptoms. The study time was very short
(30 days)
Blinding of participants and personnel High risk Participant blinding not described
(performance bias)
All outcomes
Blinding of outcome assessment (detection High risk Assessor blinding not described
bias)
All outcomes
Methods Analysis: the participants were analysed according to the grade of recovery after 14 and
21 days during the therapy to evaluate the results
Treatment duration: 20 days
Follow-up: not done
Center: not described
Design: randomised clinical trial
Notes It was not possible to define the “commercial rapid therapeutic device”
Risk of bias
Incomplete outcome data (attrition bias) Low risk All patients completed the study and there
All outcomes were no losses to follow-up, no treatment
withdrawals, no trial group changes and no
major adverse events, but there was no fol-
low-up
Selective reporting (reporting bias) Low risk The published reports include all expected
outcomes
Blinding of participants and personnel High risk Participant blinding not described
(performance bias)
All outcomes
Blinding of outcome assessment (detection High risk Assessor blinding not described
bias)
All outcomes
Zhang 2005
Methods Analysis: The participants were analysed according the grade of recovery after one month
of therapy to evaluate the results
Treatment duration: 14 days. Treatment once every other day for 14 days
Follow-up: not done
Center: not described
Design: randomised clinical trial
Outcomes The outcome was reported as 4 classes: fully recovered, highly effective, effective and no
effect. The effectiveness was judged on the measure of facial muscle strength
Full recovery: muscle strength grade V. Full functional recovery
Highly effective: muscle strength grade IV or increased by over 3 grades, functions mostly
recovered
Effective: muscle strength grade III or increased by 2 grades, functions partially recovered
No effect: muscle strength grade 0 to I or increased less than 1 grade, no change in
functions
Measurements were at day 14
Notes
Risk of bias
Incomplete outcome data (attrition bias) Low risk All participants completed the study and
All outcomes there were no losses to follow-up, no treat-
ment withdrawals, no trial group changes
and no major adverse events, but there was
no follow-up
Selective reporting (reporting bias) Low risk The published reports include all expected
outcomes
Other bias High risk The study time was very short (14 days).
There was no follow-up
Blinding of participants and personnel High risk Participant blinding not described
(performance bias)
All outcomes
Blinding of outcome assessment (detection High risk Assessor blinding not described
bias)
All outcomes
Abbreviations: TENS, transcutaneous electrical nerve stimulation; MRI, magnetic resonance imaging; SD, standard deviation.
Adour 1971 A RCT of decompression surgery for Bell’s palsy. The non surgical group received prednisolone
Balliet 1982 Not a RCT. Four people with traumatic facial paralysis
Bernardes 2004 Not a RCT. A retrospective study to delineate the contribution of myofunctional exercises during the flaccid
phase of the facial paralysis between participants with traumatic and spontaneous paralysis
Brach 1999 Not a RCT. A case study that proposed a treatment-based category based on signs and symptoms
Brown 1978 Not a RCT. A case study that described two participants treated with biofeedback in both clinic and home
environment
Cai 2010 There is no participants with idiopathic facial palsy, only traumatic facial palsy
Coulson 2006a There were only 2 participants with idiopathic facial palsy
Coulson 2006b Not a RCT. A study of 2 cases following removal of a vestibular schwannoma
Cronin 2003 Not a RCT. A retrospective case review. There are others causes of facial palsy including Ramsay Hunt. There
were only 3 participants with idiopathic facial palsy. The groups were not comparable at baseline. Twenty-
four participants received neuromuscular facial retraining and the other 6 were the control group
Danile 1982 Not a RCT. Iontophoresis was applied in 50 participants with idiopathic facial palsy without a comparison
group
Diao 2002 The “manipulation” used in the study is a Chinese traditional medicine stimulus. It is not the same manip-
ulation used in physical therapy practice
Dubravica 1996 Unclear how the groups were divided and if the participants were randomised. The 2 groups undertook
kinesiotherapy plus electrostimulation 5 weeks before the study and it could have interfered with the results
Fombeur 1988 The study divided 2 groups with 20 participants each with facial palsy of various origins
Gómez-Benítez 1995 Not a RCT. Describes the physical therapy of 42 consecutive participants with peripheric facial palsy without
describing the cause and without a control group
Hou 2008 This RCT compared results of a “experimental group” using acupuncture plus laser with a “control group”
using medication
Klingler 1982 This controlled trial concerns therapy with cortisone, antirheumatics and diuretics to treat facial palsy
Krukowska 2004 Both groups received physical therapy. The two groups had different number of participants (21 and 16
individuals)
Li 2005 The “manipulation” used in the study is a Chinese traditional medicine. It is not manipulation as used in
physical therapy practice
Lobzin 1989 Not a RCT. This is two studies with 32 participants with neuritis and neuropathy of the facial nerve treated
with an electromyography feedback device without a comparison group
Lu 2006 A quasi-RCT. The participants were grouped according to admission sequence (August, 2001 to August 2003
were the control group; September 2003 to August 2005 were the experimental group)
Manca 1997 Not a RCT. A study of 20 participants with facial paralysis treated with EMG biofeedback
Murakami 1993 Not a randomised trial. One group of people treated with low reactive-level laser therapy (11) compared with
one group treated with stellate ganglion block (26) and another group with a combination of both (15)
Nakamura 2003 There were only 10 participants with idiopathic facial palsy. 27 people with complete facial nerve palsy who
had no response to electrical stimulation were randomly allocated into 2 groups: 12 treated with training
method of biofeedback rehabilitation to prevent synkinesis and 15 as a control without treatment
Ortega-Torres 2009 A RCT that compared outcomes between 69 participants treated with laser irradiation (Arsenide of Galio)
and 69 subjects treated with hot packs, massage, electrostimulation and exercises for 10 sessions
Penteado 2009 Not a RCT. A case-series study, comparing two groups. The first group with 17 participants was submitted
to the Chevalier method and the second group with 10 participants served as control
Romero 1982 Not a RCT. Biofeedback training was applied in 10 participants with chronic facial palsy (at least 1-year
evolution) selected from a group of 957 facial paralyses cases. Only 6 individuals had idiopathic facial palsy
Ross 1991 A RCT with 31 people with long standing facial paresis (minimum of 18 months) but there were only 4
participants with idiopathic facial palsy
Segal 1995a Not a RCT. A preliminary study with 10 participants which compared a neuromuscular retraining program
(5 participants) to a group with the same treatment plus small movements to limit synkinesis (5 participants).
1 person did not have idiopathic facial palsy and it is not possible to analyse the data excluding this participant
Segal 1995b Not a RCT. A study of 25 people (5 with idiopathic paralysis) that proposed an exercise program based on
home exercises and weekly 50 to 60 minute sessions at the clinic. Reassessment was made at 2.5 month
intervals for up to 10 months with the House-Brackmann Facial Grading System and synkinesis measure.
All idiopathic participants changed from House grade 4 to grade 3 in 5 to 10 months
Shiau 1995 Not a RCT. The assessment was randomised and not the participants
Tessitore 2009 Not a RCT. 20 individuals with facial palsy of unknown etiology were compared with other 9 participants
as a control group
Zhao 2005 A controlled trial about stellate ganglion block and acupuncture
Chen 1995
Participants
Interventions
Outcomes
Notes
Shen 1998
Participants
Interventions
Outcomes
Notes
Participants
Interventions
Outcomes
Notes
Wang 1995a
Participants
Interventions
Outcomes
Notes
Wang 1995b
Participants
Interventions
Outcomes
Notes
Wang 1999
Participants
Interventions
Outcomes
Notes
Participants
Interventions
Outcomes
Notes It was not possible to source the trial. This same research group have two trials (Wong 2004; Wang 2004) published
in the same year with the same study design, similar groups, similar outcomes and similar results described in the
abstract, but we could not source Wang 2004, reason to classified it in studies awaiting classification category
Yao 1994
Participants
Interventions
Outcomes
Notes
Zhang 2003
Participants
Interventions
Outcomes
Notes
Zhuo 1990
Participants
Interventions
Outcomes
Notes
No. of No. of
Outcome or subgroup title studies participants Statistical method Effect size
1 Incomplete recovery after 6 and 1 172 Risk Ratio (M-H, Fixed, 95% CI) 1.23 [0.76, 1.99]
12 months
1.1 6 months 1 86 Risk Ratio (M-H, Fixed, 95% CI) 1.30 [0.68, 2.50]
1.2 12 months 1 86 Risk Ratio (M-H, Fixed, 95% CI) 1.15 [0.55, 2.36]
2 Mean Facial Grading Scale after 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3 months
2.1 Rest score 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Movement score 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 Total score 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Incomplete recovery after 3 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
months
4 Mean House-Brackmann Facial 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Grading Systems
5 Motor synkinesia after treatment 2 142 Risk Ratio (M-H, Fixed, 95% CI) 1.52 [0.71, 3.30]
5.1 After three months 1 56 Risk Ratio (M-H, Fixed, 95% CI) 5.0 [0.25, 99.67]
5.2 After six months 1 86 Risk Ratio (M-H, Fixed, 95% CI) 1.31 [0.59, 2.94]
No. of No. of
Outcome or subgroup title studies participants Statistical method Effect size
1 Incomplete recovery after six 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
months (all participants)
2 Incomplete recovery six months 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
according severity
2.1 Infrachordal lesion (mild 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
cases)
2.2 Suprachordal lesion 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
(severe cases)
3 Mean time to complete recovery 1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
(in days)
3.1 Infrachordal lesion (mld 1 102 Mean Difference (IV, Fixed, 95% CI) -7.42 [-13.13, -1.71]
cases)
3.2 Suprachordal lesion 1 47 Mean Difference (IV, Fixed, 95% CI) -33.94 [-63.40, -4.
(severe cases) 48]
No. of No. of
Outcome or subgroup title studies participants Statistical method Effect size
1 Recovery on Facial Grading 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Scale (Sunnybrook scale)
2 Recovery on Facial Disability 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
Index-physical
2.1 FDI-physical 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 FDI-social 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Recovery on House Brackmann 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
grading system
3.1 4 days 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 7 days 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 15 days 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
No. of No. of
Outcome or subgroup title studies participants Statistical method Effect size
1 Incomplete recovery three 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
months after randomisation
2 Mean time from the beginning 1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
of the recovery (in weeks)
2.1 Participants with mild 1 43 Mean Difference (IV, Fixed, 95% CI) -0.30 [-0.79, 0.19]
paralysis
2.2 Participants with moderate 1 47 Mean Difference (IV, Fixed, 95% CI) -1.40 [-2.22, -0.58]
paralysis
3 Mean time from completion of 1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
recovery (in weeks)
3.1 Participants with mild 1 43 Mean Difference (IV, Fixed, 95% CI) -0.40 [-1.09, 0.29]
paralysis
3.2 Participants with moderate 1 47 Mean Difference (IV, Fixed, 95% CI) -2.10 [-3.15, -1.05]
paralysis
4 Motor synkinesia after treatment 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4.1 After three months 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
No. of No. of
Outcome or subgroup title studies participants Statistical method Effect size
1 Number of participants without 2 121 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.09, 1.16]
recovery
1.1 After 14 days 1 61 Risk Ratio (M-H, Fixed, 95% CI) 0.16 [0.02, 1.26]
1.2 After 60 days 1 60 Risk Ratio (M-H, Fixed, 95% CI) 0.67 [0.12, 3.71]
2 Portmann Score 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3 Mean House Brackmann score 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
No. of No. of
Outcome or subgroup title studies participants Statistical method Effect size
1 Number of participants without 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
recovery
1.1 Shortwave diathermy 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
plus acupuncture versus
acupuncture
No. of No. of
Outcome or subgroup title studies participants Statistical method Effect size
1 Number of participants without 1 Risk Difference (M-H, Fixed, 95% CI) Totals not selected
recovery
1.1 Physical therapy versus 1 Risk Difference (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
acupuncture
1 6 months
Mosforth 1958 15/44 11/42 52.4 % 1.30 [ 0.68, 2.50 ]
0.2 0.5 1 2 5
Favours electro Favours control
Mean Mean
Study or subgroup Electrical Stimulation Control Difference Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Rest score
Manikandan 2007 28 5 (5) 28 5 (4.5) 0.0 [ -2.49, 2.49 ]
2 Movement score
Manikandan 2007 28 74 (14) 28 6 (16.7) 68.00 [ 59.93, 76.07 ]
3 Total score
Manikandan 2007 28 66 (22) 28 54 (18.9) 12.00 [ 1.26, 22.74 ]
-50 -25 0 25 50
Favours electro Favours control
Analysis 1.3. Comparison 1 Electrostimulation versus control, Outcome 3 Incomplete recovery after 3
months.
Review: Physical therapy for Bell’s palsy (idiopathic facial paralysis)
Mean Mean
Study or subgroup Electro stimulation Control Difference Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
-4 -2 0 2 4
Favours control Favours electro
Analysis 1.5. Comparison 1 Electrostimulation versus control, Outcome 5 Motor synkinesia after treatment.
0.2 0.5 1 2 5
Favours electro Favours prednisone
Analysis 2.2. Comparison 2 Electrostimulation versus prednisone, Outcome 2 Incomplete recovery six
months according severity.
0.2 0.5 1 2 5
Favours electro Favours prednisone
Mean Mean
Study or subgroup Electrostimulation Prednisone Difference Weight Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Analysis 3.1. Comparison 3 Exercise versus waiting list, Outcome 1 Recovery on Facial Grading Scale
(Sunnybrook scale).
Mean Mean
Study or subgroup Treatment Control Difference Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
-50 -25 0 25 50
Favours control Favours exercises
Mean Mean
Study or subgroup Facial exercises Control Difference Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 FDI-physical
Beurskens 2003 16 73.5 (16.8) 18 63.2 (17.9) 10.30 [ -1.37, 21.97 ]
2 FDI-social
Beurskens 2003 16 80.7 (12.2) 18 66.2 (16.4) 14.50 [ 4.85, 24.15 ]
-20 -10 0 10 20
Favours control Favours exercises
Analysis 3.3. Comparison 3 Exercise versus waiting list, Outcome 3 Recovery on House Brackmann grading
system.
1 4 days
Barbara 2010 0/9 1/11 0.40 [ 0.02, 8.78 ]
2 7 days
Barbara 2010 1/9 1/11 1.22 [ 0.09, 16.92 ]
3 15 days
Barbara 2010 5/9 3/11 2.04 [ 0.66, 6.29 ]
Analysis 4.2. Comparison 4 Exercise versus conventional treatment, Outcome 2 Mean time from the
beginning of the recovery (in weeks).
Outcome: 2 Mean time from the beginning of the recovery (in weeks)
Mean Mean
Study or subgroup Facial exercise Control Difference Weight Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
-10 -5 0 5 10
Favours treatment Favours control
Mean Mean
Study or subgroup Facial exercise Control Difference Weight Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
-10 -5 0 5 10
Favours treatment Favours control
Analysis 5.1. Comparison 5 Exercise plus acupuncture versus acupuncture, Outcome 1 Number of
participants without recovery.
Study or subgroup ACP + Exercises Acupuncture (ACP) Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 After 14 days
Zhang 2005 1/31 6/30 67.0 % 0.16 [ 0.02, 1.26 ]
Analysis 5.2. Comparison 5 Exercise plus acupuncture versus acupuncture, Outcome 2 Portmann Score.
Mean Mean
Study or subgroup Facial exercise Control Difference Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
-10 -5 0 5 10
Favours control Favours exercises
Mean Mean
Study or subgroup EXERC plus ACPT ACP Difference Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
-10 -5 0 5 10
Favours exercises Favours control
Analysis 6.1. Comparison 6 Electrotherapy plus acupuncture versus acupuncture, Outcome 1 Number of
participants without recovery.
Risk Risk
Study or subgroup Physical therapy Acupuncture Difference Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
ADDITIONAL TABLES
Table 1. Electrostimulation for Bell’s palsy (idiopathic facial paralysis)
Outcomes Illustrative comparative risks* Relative effect No of Partici- Quality of the Comments
(95% CI) (95% CI) pants evidence
(studies) (GRADE)
Control Electrostimula-
tion
Motor synkine- 11 per 100 17 per 100 RR 1.52 142 ⊕⊕
From the lim-
sis six months (8 to 38) (0.71 to 3.3) (2 studies) low1,2 ited results we
after onset inferred that no
Follow-up: 6 fur-
months ther change was
likely between 3
and 6 months,
so pooled data
for the 2 time
points. No sig-
nificant
difference
Adverse effects See comment See comment Not estimable - See comment The studies did
attributable not report on ad-
to the interven- verse events
tion - not mea-
sured
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention
(and its 95% CI).
CI: Confidence interval; RR: Risk ratio;
Outcomes Illustrative comparative risks* Relative effect No of Partici- Quality of the Comments
(95% CI) (95% CI) pants evidence
(studies) (GRADE)
Prednisone Electrostimula-
tion
Incomplete re- See comment See comment Not estimable - See comment There were no
covery after 12 studies of suffi-
months - not cient duration to
measured provide evidence
for this outcome
Motor synkine- See comment See comment Not estimable - See comment There were no
sis six months studies of suffi-
after onset - not cient duration to
reported provide evidence
for this outcome
Adverse effects See comment See comment Not estimable - See comment The study did
attributable not report on ad-
to the interven- verse events
tion - not mea-
sured
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention
(and its 95% CI).
CI: Confidence interval; RR: Risk ratio;
APPENDICES
WHAT’S NEW
Last assessed as up-to-date: 21 February 2011.
HISTORY
Protocol first published: Issue 3, 2006
Review first published: Issue 3, 2008
19 August 2011 New search has been performed The review has been updated: new searches were per-
formed and new databases included, ’Summary of find-
ings’ tables were constructed with GRADE assessments,
new relevant studies were added, comments about other
systematic reviews were included. Studies have been as-
sessed using the 2008 Cochrane ’Risk of bias tool
28 March 2011 New citation required and conclusions have changed Two authors withdrew and there is one new author (JS
Valbuza). Change to conclusions
DECLARATIONS OF INTEREST
LJT is co-author of the Cochrane overview of reviews, Interventions for Bell’s Palsy (idiopathic facial paralysis).
JSV, GFP: none known
SOURCES OF SUPPORT
Internal sources
• No sources of support supplied
External sources
• Cochrane Neuromuscular Disease Group, UK.
INDEX TERMS